. (OPTR)

$12.78 0 (0.00%)

Market Cap: $0

As of 09/16/16 12:00 AM EDT. Market closed.

(OPTR)

. (OPTR)

$12.78 0 (0.00%)

Market Cap: $0

As of 09/16/16 12:00 AM EDT. Market closed.

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$12.78
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$12.78
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Schaum Meredith Gen Counsel and Chief Comp Off Oct 24, 2013 Option Exercise $10.75 2,937 31,573 0 Oct 28, 2013, 07:51 PM
Sirota Eric Chief Operating Officer Oct 24, 2013 Option Exercise $10.75 12,129 130,387 0 Oct 28, 2013, 07:39 PM
Webster Stephen W Chief Financial Officer Oct 24, 2013 Option Exercise $10.75 25,000 268,750 16,666 Oct 28, 2013, 05:57 PM
Gorbach MD Sherwood SVP, Chief Scientific Officer Oct 24, 2013 Option Exercise $10.75 42,219 453,854 2,333 Oct 28, 2013, 05:42 PM
MCKINNELL HENRY A CEO and Chairman of the Board Oct 24, 2013 Option Exercise $10.75 35,000 376,250 25,000 Oct 28, 2013, 05:10 PM
Newman Stephen L Director Oct 24, 2013 Option Exercise $10.75 7,500 80,625 0 Oct 28, 2013, 04:50 PM
GREBOW PETER E Director Oct 24, 2013 Option Exercise $10.75 15,000 161,250 7,500 Oct 28, 2013, 03:52 PM
ZERBE ROBERT L MD Director Oct 24, 2013 Option Exercise $10.75 15,000 161,250 7,500 Oct 28, 2013, 03:22 PM
AUERBACH MARK Director Oct 24, 2013 Option Exercise $10.75 20,000 215,000 10,000 Oct 28, 2013, 03:05 PM
Chang Michael N Director Oct 24, 2013 Option Exercise $10.75 1,026,956 11,039,777 0 Oct 28, 2013, 02:43 PM
Chang Michael N Director Oct 24, 2013 Option Exercise $10.75 441,761 4,748,931 0 Oct 28, 2013, 02:43 PM
CHANG JOSEPH Y Director Oct 24, 2013 Option Exercise $10.75 46,154 496,156 0 Oct 28, 2013, 02:20 PM
CHANG JOSEPH Y Director Oct 24, 2013 Option Exercise $10.75 17,500 188,125 7,500 Oct 28, 2013, 02:20 PM
ALTIG ANTHONY E Director Oct 24, 2013 Option Exercise $10.75 20,000 215,000 15,000 Oct 25, 2013, 05:24 PM
Chang Michael N Director Sep 04, 2013 Option Exercise $8.78 94,615 830,515 432,761 Sep 06, 2013, 01:40 PM
Chang Michael N Director Sep 04, 2013 Option Exercise $8.59 178,000 1,529,480 1,026,956 Sep 06, 2013, 01:40 PM
Chang Michael N Director Sep 04, 2013 Option Exercise $11.41 9,000 102,690 441,761 Sep 06, 2013, 01:40 PM
Schaum Meredith Gen.Counsel and Chief Comp Off May 15, 2013 Option Exercise $7.53 1,789 13,473 1,789 May 17, 2013, 07:29 PM
Chang Michael N Director Apr 23, 2013 Option Exercise $1.08 117,263 127,043 848,956 Apr 25, 2013, 12:14 PM
Chang Michael N Director Apr 09, 2013 Option Exercise $12.34 103,125 1,272,563 731,693 Apr 11, 2013, 01:31 PM
LICHTINGER PEDRO Former CEO Apr 08, 2013 Option Exercise $12.69 148,000 1,877,680 252,078 Apr 10, 2013, 09:59 PM
LICHTINGER PEDRO Former CEO Apr 08, 2013 Sale $14.69 148,000 2,173,991 194,078 Apr 10, 2013, 09:59 PM
Chang Michael N Director Apr 03, 2013 Option Exercise $12.34 145,312 1,793,150 628,568 Apr 05, 2013, 08:01 PM
LICHTINGER PEDRO CEO and President Nov 08, 2012 Buy $9.08 11,000 99,847 104,078 Nov 19, 2012, 07:31 PM
CHANG JOSEPH Y Director Jun 11, 2012 Option Exercise $0.65 3,461 2,250 105,767 Jun 20, 2012, 08:42 PM
CHANG JOSEPH Y Director Jun 11, 2012 Sale $15.30 3,461 52,953 102,306 Jun 20, 2012, 08:42 PM
Papaz Gregory E. SVP, Commercial Operations May 15, 2012 Option Exercise $9.72 998 9,705 2,592 May 17, 2012, 01:58 PM
Gorbach MD Sherwood SVP, Chief Medical Officer May 15, 2012 Option Exercise $9.72 531 5,163 38,719 May 17, 2012, 01:38 PM
LICHTINGER PEDRO CEO and President May 15, 2012 Option Exercise $9.72 2,185 21,247 93,078 May 17, 2012, 01:23 PM
Shue Youe Kong VP, Clinical Development Nov 15, 2011 Option Exercise $9.72 1,186 11,533 94,230 Nov 17, 2011, 03:09 PM
Prunty John D CFO and SVP, Finance Nov 15, 2011 Option Exercise $9.72 559 5,436 12,985 Nov 17, 2011, 02:53 PM
Papaz Gregory E. SVP, Commercial Operations Nov 15, 2011 Option Exercise $9.72 1,594 15,500 1,594 Nov 17, 2011, 02:45 PM
LICHTINGER PEDRO CEO and President Nov 15, 2011 Option Exercise $9.72 173 1,682 90,893 Nov 17, 2011, 02:31 PM
Chang Michael N Director Nov 15, 2011 Option Exercise $9.72 530 5,154 338,146 Nov 17, 2011, 02:09 PM
Che Tessie M COO and SVP Nov 15, 2011 Option Exercise $9.72 530 5,154 338,146 Nov 17, 2011, 01:55 PM
ALTIG ANTHONY E Director Aug 09, 2011 Buy $7.44 5,000 37,213 5,000 Aug 09, 2011, 07:32 PM
LICHTINGER PEDRO CEO and President Aug 04, 2011 Buy $8.98 25,000 224,450 90,720 Aug 04, 2011, 05:46 PM
LICHTINGER PEDRO CEO and President Jun 30, 2011 Option Exercise $11.89 21,000 249,690 65,720 Jul 01, 2011, 11:47 AM
LICHTINGER PEDRO CEO and President May 27, 2011 Option Exercise $12.34 20,000 246,800 44,720 Jun 01, 2011, 01:30 PM
Shue Youe Kong VP, Clinical Development May 16, 2011 Option Exercise $7.71 1,484 11,441 93,044 May 17, 2011, 04:51 PM
Prunty John D CFO and SVP May 16, 2011 Option Exercise $7.71 1,928 14,864 12,426 May 17, 2011, 04:43 PM
LICHTINGER PEDRO CEO and President May 16, 2011 Option Exercise $7.71 2,500 19,274 24,720 May 17, 2011, 04:00 PM
Chang Michael N Director May 16, 2011 Option Exercise $7.71 1,971 15,195 337,616 May 17, 2011, 03:42 PM
Che Tessie M COO and SVP May 16, 2011 Option Exercise $7.71 1,971 15,195 337,616 May 17, 2011, 01:49 PM
Che Tessie M COO and SVP Apr 25, 2011 Option Exercise $1.08 100,000 108,340 478,256 Apr 27, 2011, 07:15 PM
Chang Michael N Director Apr 25, 2011 Option Exercise $1.08 100,000 108,340 478,256 Apr 27, 2011, 06:05 PM
LICHTINGER PEDRO President and CEO Feb 02, 2011 Option Exercise $12.34 20,000 246,800 22,200 Mar 22, 2011, 05:36 PM
Shue Youe Kong VP, Clinical Development Nov 15, 2010 Option Exercise $7.71 1,453 11,202 91,560 Nov 16, 2010, 06:45 PM
Shue Youe Kong VP, Clinical Development Nov 15, 2010 Option Exercise $7.71 1,453 11,202 91,560 Nov 16, 2010, 06:45 PM
Frapaise Francois-Xavier Chief Scientific Officer Nov 15, 2010 Option Exercise $7.71 1,305 10,061 4,211 Nov 16, 2010, 06:22 PM
Frapaise Francois-Xavier Chief Scientific Officer Nov 15, 2010 Option Exercise $7.71 1,305 10,061 4,211 Nov 16, 2010, 06:22 PM
Prunty John D CFO and VP, Finance Nov 16, 2010 Option Exercise $7.71 1,303 10,045 10,498 Nov 16, 2010, 06:05 PM
Prunty John D CFO and VP, Finance Nov 16, 2010 Option Exercise $7.71 1,303 10,045 10,498 Nov 16, 2010, 06:05 PM
LICHTINGER PEDRO CEO and President Nov 15, 2010 Option Exercise $7.71 2,220 17,115 2,220 Nov 16, 2010, 05:23 PM
LICHTINGER PEDRO CEO and President Nov 15, 2010 Option Exercise $7.71 2,220 17,115 2,220 Nov 16, 2010, 05:23 PM
Chang Michael N Director Nov 15, 2010 Option Exercise $7.71 1,075 8,288 335,645 Nov 16, 2010, 04:35 PM
Chang Michael N Director Nov 15, 2010 Option Exercise $7.71 1,075 8,288 378,256 Nov 16, 2010, 04:35 PM
Che Tessie M COO and SVP Nov 15, 2010 Option Exercise $7.71 1,075 8,288 335,645 Nov 16, 2010, 02:51 PM
Che Tessie M COO and SVP Nov 15, 2010 Option Exercise $7.71 1,075 8,288 335,645 Nov 16, 2010, 02:51 PM
Shue Youe Kong VP, Clinical Development Aug 30, 2010 Option Exercise $1.83 6,298 11,510 90,107 Sep 01, 2010, 04:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Schaum Meredith Gen Counsel and Chief Comp Off 10/24/2013 31,573
Sirota Eric Chief Operating Officer 10/24/2013 130,387
Webster Stephen W Chief Financial Officer 10/24/2013 268,750
Gorbach MD Sherwood SVP, Chief Scientific Officer 10/24/2013 453,854
MCKINNELL HENRY A CEO and Chairman of the Board 10/24/2013 376,250
Newman Stephen L Director 10/24/2013 80,625
GREBOW PETER E Director 10/24/2013 161,250
ZERBE ROBERT L MD Director 10/24/2013 161,250
AUERBACH MARK Director 10/24/2013 215,000
Chang Michael N Director 10/24/2013 11,039,777
Chang Michael N Director 10/24/2013 4,748,931
CHANG JOSEPH Y Director 10/24/2013 496,156
CHANG JOSEPH Y Director 10/24/2013 188,125
ALTIG ANTHONY E Director 10/24/2013 215,000
Chang Michael N Director 09/04/2013 830,515
Chang Michael N Director 09/04/2013 1,529,480
Chang Michael N Director 09/04/2013 102,690
Schaum Meredith Gen.Counsel and Chief Comp Off 05/15/2013 13,473
Chang Michael N Director 04/23/2013 127,043
Chang Michael N Director 04/09/2013 1,272,563
LICHTINGER PEDRO Former CEO 04/08/2013 1,877,680
LICHTINGER PEDRO Former CEO 04/08/2013 2,173,991
Chang Michael N Director 04/03/2013 1,793,150
LICHTINGER PEDRO CEO and President 11/08/2012 99,847
CHANG JOSEPH Y Director 06/11/2012 2,250
CHANG JOSEPH Y Director 06/11/2012 52,953
Papaz Gregory E. SVP, Commercial Operations 05/15/2012 9,705
Gorbach MD Sherwood SVP, Chief Medical Officer 05/15/2012 5,163
LICHTINGER PEDRO CEO and President 05/15/2012 21,247
Shue Youe Kong VP, Clinical Development 11/15/2011 11,533
Prunty John D CFO and SVP, Finance 11/15/2011 5,436
Papaz Gregory E. SVP, Commercial Operations 11/15/2011 15,500
LICHTINGER PEDRO CEO and President 11/15/2011 1,682
Chang Michael N Director 11/15/2011 5,154
Che Tessie M COO and SVP 11/15/2011 5,154
ALTIG ANTHONY E Director 08/09/2011 37,213
LICHTINGER PEDRO CEO and President 08/04/2011 224,450
LICHTINGER PEDRO CEO and President 06/30/2011 249,690
LICHTINGER PEDRO CEO and President 05/27/2011 246,800
Shue Youe Kong VP, Clinical Development 05/16/2011 11,441
Prunty John D CFO and SVP 05/16/2011 14,864
LICHTINGER PEDRO CEO and President 05/16/2011 19,274
Chang Michael N Director 05/16/2011 15,195
Che Tessie M COO and SVP 05/16/2011 15,195
Che Tessie M COO and SVP 04/25/2011 108,340
Chang Michael N Director 04/25/2011 108,340
LICHTINGER PEDRO President and CEO 02/02/2011 246,800
Shue Youe Kong VP, Clinical Development 11/15/2010 11,202
Shue Youe Kong VP, Clinical Development 11/15/2010 11,202
Frapaise Francois-Xavier Chief Scientific Officer 11/15/2010 10,061
Frapaise Francois-Xavier Chief Scientific Officer 11/15/2010 10,061
Prunty John D CFO and VP, Finance 11/16/2010 10,045
Prunty John D CFO and VP, Finance 11/16/2010 10,045
LICHTINGER PEDRO CEO and President 11/15/2010 17,115
LICHTINGER PEDRO CEO and President 11/15/2010 17,115
Chang Michael N Director 11/15/2010 8,288
Chang Michael N Director 11/15/2010 8,288
Che Tessie M COO and SVP 11/15/2010 8,288
Che Tessie M COO and SVP 11/15/2010 8,288
Shue Youe Kong VP, Clinical Development 08/30/2010 11,510
Load More Insider Transactions